Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
OMER · against 458 other Healthcare companies of similar size
Ranked #457 of 459 · scores higher than 0% of peers · safety percentile 1
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)41 peers with a safety percentile of 0–9, including OMER · Click a bar to see the companies
Mainly because of its debt / equity, beta and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | OMER | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 434 reported | Not reported | 0.21× | — | — | 33% |
| BetaLower is better · 430 reported | 2.60 | 0.49 | 1% | 33% | |
| Current ratioHigher is better · 444 reported | 1.95× | 2.87× | 36% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 453 | 2.0B USD | 2 | 27 | |
| 454 | 222.9B JPY (≈$1.5B) | 2 | 53 | |
| 455 | 1.2B CHF (≈$1.3B) | 1 | 28 | |
| 456 | 1.6B USD | 1 | 7 | |
| 457 | 1.3B USD | 1 | 29 | |
| 458 | 693M USD | 1 | ||
| 459 | 5.2B CNY (≈$723M) | 0 | 9 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score